Long-Term Results of Atrioventricular Node Ablation After His Bundle Pacing in Uncontrolled Atrial Tachyarrhythmias.

IF 1.3
Pacing and clinical electrophysiology : PACE Pub Date : 2025-07-01 Epub Date: 2025-06-19 DOI:10.1111/pace.70000
María Teresa Moraleda-Salas, Ane Erkoreka-Gasituaga, Carlos Perea-Alfaro, Irene Esteve-Ruiz, Álvaro Arce-León, José Miguel Carreño-Lineros, Emilio Amigo-Otero, María Del Mar Moraleda-Salas, Santiago Camacho-Freire, Francisco Navarro-Roldan, Pablo Moriña-Vázquez
{"title":"Long-Term Results of Atrioventricular Node Ablation After His Bundle Pacing in Uncontrolled Atrial Tachyarrhythmias.","authors":"María Teresa Moraleda-Salas, Ane Erkoreka-Gasituaga, Carlos Perea-Alfaro, Irene Esteve-Ruiz, Álvaro Arce-León, José Miguel Carreño-Lineros, Emilio Amigo-Otero, María Del Mar Moraleda-Salas, Santiago Camacho-Freire, Francisco Navarro-Roldan, Pablo Moriña-Vázquez","doi":"10.1111/pace.70000","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In the evolving treatment of atrial fibrillation (AF), atrioventricular (AV) node ablation is being reconsidered as an early option for patients with inadequate AF control and limited cure potential. Although interest in physiological pacing is growing, concerns about the long-term safety of permanent His bundle pacing (p-HBP) persist. Our current study aims to evaluate the long-term outcomes of patients who underwent AV node ablation and p-HBP, focusing on left ventricular ejection fraction (LVEF), NYHA class, readmissions, and pacing parameters.</p><p><strong>Methods: </strong>This descriptive observational study involved patients with uncontrolled permanent atrial arrhythmias who were eligible for heart rate (HR) control (between January 2019 and July 2020) and underwent p-HBP and AV node ablation, followed during a near 4-year period.</p><p><strong>Results: </strong>We conducted a long-term follow-up study with a median duration of 47 months on 32 patients who received p-HBP followed by AV node ablation. The average age was 77 years, predominantly female (65.6%), with a high prevalence of hypertension (90.6%). The main indications for ablation were uncontrolled AF (59.4%) and atypical atrial flutter (37.5%). At baseline, the median LVEF was 60%. Notably, LVEF improved significantly from 45% to 50% in those with reduced baseline function (p < 0.05). NYHA class improvements were also observed over time. The His thresholds remained similar during long-term follow-up, being 1.25 V at 0.4 ms (1.25-2.4 V at 0.4 ms) before AV node ablation and 1.30 V at 0.4 ms (0.75-2.25 V at 0.4 ms), p = 0.89, at long-term follow-up. The impedances remained stable. No complications related to the pacemaker occurred. Number of medications per patient for HR control significantly decreased from 1.6 to 0.37 (p < 0.05), while hospital admissions for tachyarrhythmias dropped markedly. There was one death during the follow-up due to cancer, but conclusions regarding mortality are limited by the small sample size.</p><p><strong>Conclusions: </strong>AV node ablation and p-HBP significantly improve functional class and LVEF, with benefits maintained over time. Patients experience fewer emergency visits and reduced HR medication. Pacing parameters remained stable during long-term follow-up.</p>","PeriodicalId":520740,"journal":{"name":"Pacing and clinical electrophysiology : PACE","volume":" ","pages":"799-806"},"PeriodicalIF":1.3000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pacing and clinical electrophysiology : PACE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/pace.70000","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: In the evolving treatment of atrial fibrillation (AF), atrioventricular (AV) node ablation is being reconsidered as an early option for patients with inadequate AF control and limited cure potential. Although interest in physiological pacing is growing, concerns about the long-term safety of permanent His bundle pacing (p-HBP) persist. Our current study aims to evaluate the long-term outcomes of patients who underwent AV node ablation and p-HBP, focusing on left ventricular ejection fraction (LVEF), NYHA class, readmissions, and pacing parameters.

Methods: This descriptive observational study involved patients with uncontrolled permanent atrial arrhythmias who were eligible for heart rate (HR) control (between January 2019 and July 2020) and underwent p-HBP and AV node ablation, followed during a near 4-year period.

Results: We conducted a long-term follow-up study with a median duration of 47 months on 32 patients who received p-HBP followed by AV node ablation. The average age was 77 years, predominantly female (65.6%), with a high prevalence of hypertension (90.6%). The main indications for ablation were uncontrolled AF (59.4%) and atypical atrial flutter (37.5%). At baseline, the median LVEF was 60%. Notably, LVEF improved significantly from 45% to 50% in those with reduced baseline function (p < 0.05). NYHA class improvements were also observed over time. The His thresholds remained similar during long-term follow-up, being 1.25 V at 0.4 ms (1.25-2.4 V at 0.4 ms) before AV node ablation and 1.30 V at 0.4 ms (0.75-2.25 V at 0.4 ms), p = 0.89, at long-term follow-up. The impedances remained stable. No complications related to the pacemaker occurred. Number of medications per patient for HR control significantly decreased from 1.6 to 0.37 (p < 0.05), while hospital admissions for tachyarrhythmias dropped markedly. There was one death during the follow-up due to cancer, but conclusions regarding mortality are limited by the small sample size.

Conclusions: AV node ablation and p-HBP significantly improve functional class and LVEF, with benefits maintained over time. Patients experience fewer emergency visits and reduced HR medication. Pacing parameters remained stable during long-term follow-up.

无控制房性心动过速患者束状起搏后房室结消融的长期结果。
导读:在不断发展的房颤治疗中,房室结消融正被重新考虑作为房颤控制不足和治愈潜力有限的患者的早期选择。尽管对生理起搏的兴趣越来越大,但对永久性His束起搏(p-HBP)长期安全性的担忧仍然存在。我们目前的研究旨在评估接受房室结消融和p-HBP治疗的患者的长期预后,重点关注左室射血分数(LVEF)、NYHA分级、再入院率和起搏参数。方法:这项描述性观察性研究纳入了不受控制的永久性心房心律失常患者,这些患者符合心率(HR)控制条件(2019年1月至2020年7月),并接受了p-HBP和房室结消融,随访时间近4年。结果:我们对32例接受p-HBP并房室结消融的患者进行了中位持续时间为47个月的长期随访研究。平均年龄77岁,以女性为主(65.6%),高血压患病率高(90.6%)。消融的主要适应症为未控制的房颤(59.4%)和不典型心房扑动(37.5%)。基线时,中位LVEF为60%。值得注意的是,基线功能降低的患者LVEF从45%显著改善到50% (p结论:房室结消融和p- hbp显著改善功能分级和LVEF,并随时间保持益处。患者急诊次数减少,HR用药减少。长期随访期间起搏参数保持稳定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信